Prolonged Response to an IGF-1 Receptor Antibody in a Patient with Metastatic Castration Prostate Cancer with Neuroendocrine Differentiation
Julie N. Graff(Seattle Cancer Care Alliance), Tomasz M. Beer(Oregon Health & Science University)
Cited by 5
Related Papers
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone
|Journal for ImmunoTherapy of Cancer|2020|120